J&J Awaits Final Clearance to Re-Open Suspended Tylenol Plant, $100M and Five Years Later

Source: Philadelphia Business Journal

Jul 17, 2015

After suspending manufacturing at its Consumer Healthcare plant five years ago, Johnson & Johnson's McNeil says it is now awaiting final notification from the FDA before re-opening.

Following a lengthy series of recalls involving millions of product packages, McNeil had suspended manufacturing at its Fort Washington, PA location -- the drugmaker's primary Tylenol and OTC manufacturing site.

McNeil says it recently had a successful FDA inspection at the site, after spending over $100 million on plant improvements.

Read the Philly Business Journal article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments